{"hands_on_practices": [{"introduction": "The purpose of Preimplantation Genetic Testing for Monogenic disease (PGT-M) is to make informed choices based on the genetic status of an embryo. Before any testing occurs, the foundation of genetic counseling is to establish the baseline risk, which is determined by the parents' genotypes and the fundamental laws of Mendelian inheritance. This first exercise [@problem_id:5073655] provides practice in calculating these essential a priori probabilities for a classic autosomal recessive scenario, forming the basis for all subsequent risk assessment.", "problem": "A couple is pursuing Preimplantation Genetic Testing for Monogenic disease (PGT-M) because both partners are known carriers of the same pathogenic variant in an autosomal recessive gene. Let the normal allele be denoted by $A$ and the pathogenic allele by $a$. Each parent therefore has genotype $A a$. Assume the following fundamental principles: Mendel’s law of segregation applies at this locus; each gamete receives one allele with equal probability; fertilization is random; there is no selection, de novo mutation, segregation distortion, or technical bias at the embryo stage.\n\nUnder these assumptions, and using only first-principles reasoning from Mendelian inheritance, compute the expected proportions of embryos in each clinically relevant category: affected ($a a$), carriers ($A a$), and non-carriers ($A A$). Express the final result as exact fractions in simplest form and present your answer as a single row matrix in the order $(\\text{affected}, \\text{carriers}, \\text{non-carriers})$. No rounding is required, and do not use a percentage sign; provide fractions or decimals as appropriate.", "solution": "The problem statement is evaluated and found to be valid. It is a well-posed, scientifically grounded problem based on the fundamental principles of Mendelian genetics. All necessary information and simplifying assumptions are provided, and there are no contradictions or ambiguities. We may proceed with the solution.\n\nThe problem asks for the expected proportions of embryos in three categories—affected, carriers, and non-carriers—resulting from a cross between two parents who are both heterozygous carriers for an autosomal recessive condition. Let the normal allele be denoted by $A$ and the pathogenic (recessive) allele by $a$. Both parents have the genotype $A a$.\n\nThe solution is derived from first principles, specifically Mendel's law of segregation and the principle of random fertilization, as stipulated.\n\nFirst, we determine the possible gametes produced by each parent and their respective probabilities. According to the law of segregation, the two alleles ($A$ and $a$) at a genetic locus separate from each other during gamete formation, so that each gamete receives only one of the two alleles. The problem states that each allele is passed to a gamete with equal probability.\n\nFor Parent 1, with genotype $A a$, the possible gametes are $A$ and $a$.\nThe probability of a gamete from Parent 1 containing allele $A$ is $P(\\text{gamete}_1 = A) = \\frac{1}{2}$.\nThe probability of a gamete from Parent 1 containing allele $a$ is $P(\\text{gamete}_1 = a) = \\frac{1}{2}$.\n\nSimilarly, for Parent 2, with genotype $A a$, the possible gametes are also $A$ and $a$.\nThe probability of a gamete from Parent 2 containing allele $A$ is $P(\\text{gamete}_2 = A) = \\frac{1}{2}$.\nThe probability of a gamete from Parent 2 containing allele $a$ is $P(\\text{gamete}_2 = a) = \\frac{1}{2}$.\n\nNext, we consider the process of fertilization. The problem assumes fertilization is random, which means the combination of any gamete from Parent 1 with any gamete from Parent 2 is an independent event. The probability of a specific offspring genotype is therefore the product of the probabilities of the two gametes that form the zygote.\n\nWe can enumerate the possible genotypes of the offspring and calculate their probabilities:\n\n1.  **Genotype $A A$ (non-carrier):** This outcome requires the fusion of a gamete containing allele $A$ from Parent 1 and a gamete containing allele $A$ from Parent 2.\n    The probability is:\n    $$P(A A) = P(\\text{gamete}_1 = A) \\times P(\\text{gamete}_2 = A) = \\frac{1}{2} \\times \\frac{1}{2} = \\frac{1}{4}$$\n    This corresponds to the \"non-carrier\" category.\n\n2.  **Genotype $a a$ (affected):** This outcome requires the fusion of a gamete containing allele $a$ from Parent 1 and a gamete containing allele $a$ from Parent 2.\n    The probability is:\n    $$P(a a) = P(\\text{gamete}_1 = a) \\times P(\\text{gamete}_2 = a) = \\frac{1}{2} \\times \\frac{1}{2} = \\frac{1}{4}$$\n    This corresponds to the \"affected\" category, as the disease is autosomal recessive.\n\n3.  **Genotype $A a$ (carrier):** This heterozygous outcome can occur in two mutually exclusive ways:\n    a) A gamete with allele $A$ from Parent 1 fertilizes a gamete with allele $a$ from Parent 2. The probability of this event is $P(A \\text{ from } 1, a \\text{ from } 2) = P(\\text{gamete}_1 = A) \\times P(\\text{gamete}_2 = a) = \\frac{1}{2} \\times \\frac{1}{2} = \\frac{1}{4}$.\n    b) A gamete with allele $a$ from Parent 1 fertilizes a gamete with allele $A$ from Parent 2. The probability of this event is $P(a \\text{ from } 1, A \\text{ from } 2) = P(\\text{gamete}_1 = a) \\times P(\\text{gamete}_2 = A) = \\frac{1}{2} \\times \\frac{1}{2} = \\frac{1}{4}$.\n    The total probability of the offspring having the genotype $A a$ is the sum of the probabilities of these two events:\n    $$P(A a) = \\left(\\frac{1}{2} \\times \\frac{1}{2}\\right) + \\left(\\frac{1}{2} \\times \\frac{1}{2}\\right) = \\frac{1}{4} + \\frac{1}{4} = \\frac{2}{4} = \\frac{1}{2}$$\n    This corresponds to the \"carrier\" category.\n\nThe sum of the probabilities for all possible genotypes must equal $1$:\n$$P(A A) + P(a a) + P(A a) = \\frac{1}{4} + \\frac{1}{4} + \\frac{1}{2} = 1$$\nThis confirms the completeness and consistency of the calculation.\n\nThe problem asks for the expected proportions of embryos in the order (affected, carriers, non-carriers). These proportions are numerically equal to the probabilities calculated.\n-   Proportion affected ($a a$): $\\frac{1}{4}$\n-   Proportion carriers ($A a$): $\\frac{1}{2}$\n-   Proportion non-carriers ($A A$): $\\frac{1}{4}$\n\nThe final result is presented as a row matrix of these exact fractions in the specified order.", "answer": "$$\n\\boxed{\n\\begin{pmatrix}\n\\frac{1}{4}  \\frac{1}{2}  \\frac{1}{4}\n\\end{pmatrix}\n}\n$$", "id": "5073655"}, {"introduction": "While Mendelian genetics gives us the theoretical risk, the real-world utility of PGT-M depends on the accuracy of the diagnostic test itself. No test is perfect, and its performance is described by its sensitivity and specificity. This practice problem [@problem_id:5073651] demonstrates how to use these metrics, along with the prior risk, to calculate the positive and negative predictive values, which quantify the confidence we can have in a given test result.", "problem": "A couple in which both individuals are confirmed heterozygous carriers for a known pathogenic variant causing an autosomal recessive monogenic disease undergo in vitro fertilization with Preimplantation Genetic Testing for Monogenic disease (PGT-M). Under Mendelian inheritance, the probability that a randomly selected embryo is affected is $0.25$. A laboratory assay for PGT-M has sensitivity $0.98$ and specificity $0.995$, where sensitivity is defined as $P(+ \\mid D)$ and specificity is defined as $P(- \\mid \\overline{D})$, with $D$ denoting the event that an embryo is affected and $+$ denoting a positive test result.\n\nUsing the definitions of sensitivity, specificity, pre-test probability, and Bayes’ theorem, compute the positive predictive value $P(D \\mid +)$ and negative predictive value $P(\\overline{D} \\mid -)$ for this assay in this clinical context. Express both values as decimal probabilities without a percentage sign, and round each to four significant figures. Report your two final values in the order positive predictive value and negative predictive value.", "solution": "The problem statement is evaluated to be scientifically grounded, well-posed, objective, and self-contained. The provided data regarding Mendelian inheritance for an autosomal recessive condition and the definitions of assay sensitivity and specificity are consistent with established principles in genetics and medical statistics. No flaws were identified. We may therefore proceed with a formal solution.\n\nThe problem requires the calculation of the positive predictive value (PPV) and the negative predictive value (NPV) of a preimplantation genetic test. We are given the following information:\n\nLet $D$ be the event that an embryo is affected by the monogenic disease.\nLet $\\overline{D}$ be the event that an embryo is not affected.\nLet $+$ be the event that the test result is positive.\nLet $-$ be the event that the test result is negative.\n\nThe givens are:\nThe pre-test probability, or prevalence, of an affected embryo is $P(D) = 0.25$. This is derived from Mendelian genetics for an autosomal recessive disease where both parents are heterozygous carriers. The probability of an unaffected embryo is therefore the complement:\n$$P(\\overline{D}) = 1 - P(D) = 1 - 0.25 = 0.75$$\n\nThe sensitivity of the assay is the probability of a positive test given that the embryo is affected:\n$$P(+ \\mid D) = 0.98$$\n\nThe specificity of the assay is the probability of a negative test given that the embryo is not affected:\n$$P(- \\mid \\overline{D}) = 0.995$$\n\nFrom these definitions, we can derive the probabilities of erroneous test results:\nThe false negative rate is the probability of a negative test given that the embryo is affected:\n$$P(- \\mid D) = 1 - P(+ \\mid D) = 1 - 0.98 = 0.02$$\n\nThe false positive rate is the probability of a positive test given that the embryo is not affected:\n$$P(+ \\mid \\overline{D}) = 1 - P(- \\mid \\overline{D}) = 1 - 0.995 = 0.005$$\n\nOur objective is to compute the positive predictive value, $P(D \\mid +)$, and the negative predictive value, $P(\\overline{D} \\mid -)$. We will use Bayes' theorem for these calculations.\n\nFirst, we compute the positive predictive value, $P(D \\mid +)$. Bayes' theorem states:\n$$P(D \\mid +) = \\frac{P(+ \\mid D) P(D)}{P(+)}$$\nTo use this formula, we must first find $P(+)$, the total probability of a positive test result. We use the law of total probability:\n$$P(+) = P(+ \\mid D) P(D) + P(+ \\mid \\overline{D}) P(\\overline{D})$$\nSubstituting the known values:\n$$P(+) = (0.98)(0.25) + (0.005)(0.75)$$\n$$P(+) = 0.245 + 0.00375$$\n$$P(+) = 0.24875$$\nNow we can compute the positive predictive value:\n$$P(D \\mid +) = \\frac{0.245}{0.24875} \\approx 0.984924677$$\nRounding to four significant figures, we get $P(D \\mid +) = 0.9849$.\n\nNext, we compute the negative predictive value, $P(\\overline{D} \\mid -)$. The corresponding form of Bayes' theorem is:\n$$P(\\overline{D} \\mid -) = \\frac{P(- \\mid \\overline{D}) P(\\overline{D})}{P(-)}$$\nFirst, we find $P(-)$, the total probability of a negative test result. We again use the law of total probability:\n$$P(-) = P(- \\mid D) P(D) + P(- \\mid \\overline{D}) P(\\overline{D})$$\nSubstituting the known values:\n$$P(-) = (0.02)(0.25) + (0.995)(0.75)$$\n$$P(-) = 0.005 + 0.74625$$\n$$P(-) = 0.75125$$\nNote that $P(+) + P(-) = 0.24875 + 0.75125 = 1$, which confirms the consistency of our calculations for the marginal probabilities of the test outcomes.\nNow we can compute the negative predictive value:\n$$P(\\overline{D} \\mid -) = \\frac{(0.995)(0.75)}{0.75125} = \\frac{0.74625}{0.75125} \\approx 0.99334442$$\nRounding to four significant figures, we get $P(\\overline{D} \\mid -) = 0.9933$.\n\nThe positive predictive value is approximately $0.9849$ and the negative predictive value is approximately $0.9933$.", "answer": "$$\n\\boxed{\n\\begin{pmatrix}\n0.9849  0.9933\n\\end{pmatrix}\n}\n$$", "id": "5073651"}, {"introduction": "The accuracy of PGT-M can be compromised by natural biological events, such as genetic recombination, especially when the disease-causing variant is not tested directly but inferred using linked genetic markers. Thoughtful test design is crucial for minimizing the chances of such an error. This exercise [@problem_id:5073704] explores how recombination creates a risk of misdiagnosis and quantitatively demonstrates why using two flanking markers is vastly superior to using a single marker.", "problem": "In Preimplantation Genetic Testing for Monogenic disease (PGT-M), phased linkage analysis is used to infer the disease allele in an embryo using informative flanking markers. Consider a single at-risk parent transmitting one of two haplotypes containing a disease locus. Assume the following fundamental base facts: (i) the recombination fraction $r$ between two loci equals the probability that a gamete is recombinant between those loci, (ii) for small genetic distances, the genetic map distance $d$ in centiMorgans (cM) approximates the recombination fraction via $r \\approx d/100$, and (iii) if recombination events in adjacent intervals are independent and interference is negligible over small distances, then the joint probability of recombination in two non-overlapping intervals equals the product of their individual recombination fractions.\n\nA clinic considers two designs for PGT-M linkage-based diagnosis of an autosomal dominant disease:\n\n- Design A: a single informative flanking marker at genetic distance $0.8$ centiMorgans (cM) from the disease locus on one side.\n- Design B: two informative flanking markers, one on each side of the disease locus, at genetic distances $0.3$ cM and $0.5$ cM from the disease locus, respectively.\n\nAssume misdiagnosis arises only from recombination and that other sources of error are negligible. Using the fundamental base facts above, derive from first principles the residual risk of misdiagnosis due to recombination for each design. Then compute the fold-reduction factor in misdiagnosis risk when using Design B relative to Design A, defined as the ratio\n$$\nF \\equiv \\frac{\\text{residual risk in Design A}}{\\text{residual risk in Design B}}.\n$$\nRound your final answer for $F$ to four significant figures. Express your answer as a unitless decimal number without a percentage sign.", "solution": "The problem statement has been validated and is deemed valid. It is scientifically grounded in the principles of genetic linkage and recombination, well-posed with all necessary data and clear objectives, and framed in objective, formal language. It is free of the flaws listed in the validation criteria. We may therefore proceed with the solution.\n\nThe problem asks for the derivation of the residual risk of misdiagnosis for two PGT-M designs and the computation of the fold-reduction in risk of Design B relative to Design A. The risk of misdiagnosis is stated to arise solely from recombination events.\n\nLet $r$ be the recombination fraction between two loci and $d$ be the genetic distance in centiMorgans (cM). The problem provides the approximation $r \\approx \\frac{d}{100}$ for small distances.\n\n**Analysis of Design A**\n\nIn Design A, a single informative flanking marker is used, located at a genetic distance $d_A = 0.8$ cM from the disease locus. Let the disease allele be $D$ and the corresponding wild-type allele be $d$. Let the marker allele on the same chromosome as $D$ in the at-risk parent be $M_D$, and the marker allele on the chromosome with $d$ be $M_d$. The parental haplotypes are thus $(D, M_D)$ and $(d, M_d)$.\n\nThe diagnostic inference is that the presence of the marker $M_D$ implies the presence of the disease allele $D$, and the presence of $M_d$ implies the presence of the wild-type allele $d$. A misdiagnosis occurs if a recombination event happens between the disease locus and the marker locus during meiosis in the at-risk parent. This would produce recombinant gametes: $(D, M_d)$ and $(d, M_D)$.\n\nFor example, if an embryo inherits the recombinant haplotype $(d, M_D)$, the PGT-M test would detect the marker $M_D$ and incorrectly infer the presence of the disease allele $D$, leading to a false-positive diagnosis. The probability of such a misdiagnosis is, by definition, the recombination fraction between the two loci.\n\nThe residual risk for Design A, denoted $Risk_A$, is therefore equal to the recombination fraction $r_A$.\n$$\nRisk_A = r_A\n$$\nUsing the provided approximation with $d_A = 0.8$ cM:\n$$\nRisk_A \\approx \\frac{d_A}{100} = \\frac{0.8}{100} = 0.008\n$$\n\n**Analysis of Design B**\n\nIn Design B, two informative flanking markers are used. Let the markers be $M_1$ and $M_2$, positioned on opposite sides of the disease locus. The genetic distances are $d_{B1} = 0.3$ cM (between $M_1$ and the disease locus) and $d_{B2} = 0.5$ cM (between the disease locus and $M_2$). The gene order is $M_1 - D - M_2$.\n\nLet the haplotypes in the at-risk parent be $(M_1, D, M_2)$ and $(m_1, d, m_2)$, where $m_1$ and $m_2$ are the alternative marker alleles. The diagnosis is based on the combined marker results. The marker haplotype $(M_1, M_2)$ is interpreted as indicating the presence of the disease allele $D$, while $(m_1, m_2)$ is interpreted as indicating the wild-type allele $d$.\n\nA misdiagnosis in this design can only occur if the set of markers inherited by the embryo appears non-recombinant, but the disease allele status is opposite to what is inferred. This happens as a result of a double crossover event.\n\nConsider a single recombination event, for instance between marker $M_1$ and the disease locus. This would produce gametes with haplotypes $(m_1, D, M_2)$ and $(M_1, d, m_2)$. In the first case, the embryo inherits the marker set $(m_1, M_2)$. This is a recombinant marker haplotype, which is distinguishable from the parental marker haplotypes $(M_1, M_2)$ and $(m_1, m_2)$. The genetic testing laboratory would recognize that a recombination has occurred and would not make a simple (and possibly incorrect) diagnostic call. Therefore, a single crossover event between the markers leads to an informative, albeit complex, result, not a misdiagnosis as defined.\n\nA misdiagnosis arises when a double crossover occurs, with one crossover in the interval between $M_1$ and the disease locus, and a second crossover in the interval between the disease locus and $M_2$. Such an event would produce the gamete haplotypes $(M_1, d, M_2)$ and $(m_1, D, m_2)$.\nIf an embryo inherits $(M_1, d, M_2)$, the marker haplotype is $(M_1, M_2)$, which appears non-recombinant. The diagnosis would be \"affected,\" but the embryo actually carries the wild-type allele $d$, a false-positive.\nIf an embryo inherits $(m_1, D, m_2)$, the marker haplotype is $(m_1, m_2)$, also appearing non-recombinant. The diagnosis would be \"unaffected,\" but the embryo carries the disease allele $D$, a false-negative.\n\nThe probability of a misdiagnosis, $Risk_B$, is the probability of such a double crossover event occurring. The problem states that recombination events in adjacent intervals are independent. Therefore, the probability of a double crossover is the product of the individual recombination fractions for the two intervals.\n\nThe recombination fraction for the first interval is $r_{B1}$:\n$$\nr_{B1} \\approx \\frac{d_{B1}}{100} = \\frac{0.3}{100} = 0.003\n$$\nThe recombination fraction for the second interval is $r_{B2}$:\n$$\nr_{B2} \\approx \\frac{d_{B2}}{100} = \\frac{0.5}{100} = 0.005\n$$\nThe residual risk for Design B is the product of these probabilities:\n$$\nRisk_B = r_{B1} \\times r_{B2} = (0.003) \\times (0.005) = 0.000015\n$$\n\n**Calculation of the Fold-Reduction Factor**\n\nThe fold-reduction factor $F$ is defined as the ratio of the risk in Design A to the risk in Design B.\n$$\nF = \\frac{Risk_A}{Risk_B}\n$$\nSubstituting the calculated values:\n$$\nF = \\frac{0.008}{0.000015} = \\frac{8 \\times 10^{-3}}{15 \\times 10^{-6}} = \\frac{8}{15} \\times 10^3 = \\frac{8000}{15}\n$$\nPerforming the division:\n$$\nF = \\frac{1600}{3} = 533.3333...\n$$\nThe problem requires rounding the final answer to four significant figures.\n$$\nF \\approx 533.3\n$$\nThis result demonstrates a substantial improvement in diagnostic accuracy when using two flanking markers compared to a single marker, primarily because misdiagnosis then requires a much rarer double-recombination event.", "answer": "$$\\boxed{533.3}$$", "id": "5073704"}]}